medicine shortages
Taking action on shortages
TGA and Medicines Australia respond to pharmacist survey on medicines shortages, saying changes have been made but there is scope for improvement The TGA and Medicines Australia have noted concerns …
Ozempic shortage extends into new year – but it’s still earning big
Meanwhile semaglutide medication Wegovy – indicated purely for weight loss – is added to the ARTG The enduring drought of type-2 diabetes medication Ozempic, blamed on its being prescribed off-label …
‘Unacceptable and unsustainable’: Meds shortages take toll
Pharmacists are spending significant additional hours managing medicines shortages, with some reporting up to 600 shortages in one week, a profession-wide survey has found Medicine shortages remain a “substantial problem” …
Reduce or run out
Healthcare professionals urged to conserve tenecteplase (Metalyse) in wake of shortage due to surging global demand, to maintain continuity of supply for patients Boehringer Ingelheim Australia has advised the TGA …
Ozempic shortages until December
Diabetes medication shortfall “worse than ever” The long-running shortage of diabetes drug Ozempic (semaglutide) looks set to continue until at least the end of the year, according to a revised …
Naloxone Take Home program prompts shortage
Next major import of drug not due until mid-November Just six weeks after the launch of the national Take Home Naloxone program there is already a significant shortage of the …
Confronting ‘dire’ medicine shortages
With over 400 medicines facing shortages, the industry says it’s working to minimise the impact As medicines shortages continue to increase, Australian peak bodies say they are “deeply concerned” about …
A return to ‘pre-pandemic levels’
Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations …
Shelf-life extensions granted
Shortage of tenecteplase (Metalyse) injections has been advised after surging global demand Boehringer Ingelheim Australia has advised the TGA of “the likelihood of temporary supply interruptions” to tenecteplase (Metalyse) injection …
Supply ‘constrained’ but improving
Substitution instrument extended for abatacept, while others end The Serious Scarcity Substitution Instrument (SSSI) for abatacept (Orencia), originally set to expire on 30 April, has been extended until 30 June. …
Flu rebound season likely
Vaccinators have been asked not to forget that other contagious and potentially deadly respiratory illness: it’s time to order flu jabs The Immunisation Coalition is urging healthcare providers, including pharmacists, …
World news wrapup: 21 October 2021
Afghanistan faces meds shortages; Canada pharmacy allegedly repeatedly targeted for arson; anti-vaccinators vandalise Belfast pharmacy Kabul, Afghanistan: Following the takeover of Afghanistan by the Taliban, pharmacy owners are warning that …